Global Healthcare Nanotechnology (Nanomedicine) Market

One of the most promising and sought-after technologies in 21st Century is Nanotechnology and with path breaking advancements in the field it is stated to reach USD XX by 20XX. The term Nanotechnology is used when the developments occur at very miniscule 0.1 to 100 nm scale. Nanomedicine is an offshoot of Nanotechnology which basically involves development of medicines at a molecular stage. The medicines ae developed for treatment of life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, etc. These also have various other applications such as diagnosis, prevention and even regeneration of tissues.

The development of a nanomedicine is a tedious process and usually takes several years. These are based on technologies such as quantum dots, nanorobots, nanorods, nanoparticles, fullerenes, liposomes and more. The diagnosis field has more precise and reliable nanotechnology methods. These require minimum biological sample which facilitates considerable reduction in consumption of reagents and disposables. This technology is also widely used in drug delivery purpose due to nanoscale particles.

Market Dynamics

A number of factors drive the market for Nanomedicine. The improvement in regulatory framework, the technology becoming more familiar, heavy funding and a positive mindset by the governments of various countries help its cause. Apart from these, a continuous increase in the aforementioned chronic diseases has been observed. Thus, there has been a phenomenal rise in the demand of nanomedicines. With new companies stated to enter the market, the supply-demand gap of nanomedicines will be bridged to a larger extent. There are debates on the toxicity of these medicines and the high cost associated to it but currently, the benefits outweigh the riskinvolved.

Market Segmentation

The basis of segmentation of this market is applications in medicines, targeted disease and geography. The application segment includes, drug delivery, drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging where drug delivery contributes higher than rest followed by in-vitro diagnostics. It is divided on the basis of diseases in the following segments: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Till 2012, the market was heavily dominated by oncology segment however currently, the cardiovascular nanomedicine market is the fastest growing.

Regional/Geographic Analysis

The market was heavily dominated by the US but there has been a rise in the Asia Pacific region and is expected to grow faster owing to a rapid increase in geriatric population and rising awareness of healthcare. Even Europe is stated to grow faster than the US due to its extensive product pipeline portfolio and improving regulatory frameworks.

Key Players

Some of the major players in the market include GE Healthcare, Abbott Laboratories,Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage